Stuttgart - Delayed Quote EUR

Aptose Biosciences Inc. (LTI0.SG)

1.4000
-0.0300
(-2.10%)
At close: May 9 at 9:32:56 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
26,257
26,257
52,356
42,602
65,447
Operating Income
-26,257
-26,257
-52,356
-42,602
-65,447
Net Non Operating Interest Income Expense
150
150
1,151
788
94
Other Income Expense
677
677
-2
-9
-1
Pretax Income
-25,430
-25,430
-51,207
-41,823
-65,354
Net Income Common Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Diluted NI Available to Com Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Basic EPS
-36.38
--
-227.43
-204.00
-328.50
Diluted EPS
-36.38
--
-227.43
-204.00
-328.50
Basic Average Shares
698.9790
--
225.1540
205.0330
197.9680
Diluted Average Shares
698.9790
--
225.1540
205.0330
197.9680
Total Expenses
26,257
26,257
52,356
42,602
65,447
Net Income from Continuing & Discontinued Operation
-25,430
-25,430
-51,207
-41,823
-65,354
Normalized Income
-26,107
-26,107
-51,205
-41,814
-65,353
Interest Income
357
357
1,151
788
94
Interest Expense
207
207
0
--
--
Net Interest Income
150
150
1,151
788
94
EBIT
-25,223
-25,223
-51,207
-42,602
-65,447
EBITDA
-24,819
-24,819
-50,741
-42,074
-64,825
Reconciled Depreciation
404
404
466
528
622
Net Income from Continuing Operation Net Minority Interest
-25,430
-25,430
-51,207
-41,823
-65,354
Total Unusual Items Excluding Goodwill
677
677
-2
-9
-1
Total Unusual Items
677
677
-2
-9
-1
Normalized EBITDA
-25,496
-25,496
-50,739
-42,065
-64,824
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/27/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TYRA Tyra Biosciences, Inc.
10.09
+0.20%
 
SER Serina Therapeutics, Inc.
5.63
-2.01%
 
ARMP Armata Pharmaceuticals, Inc.
1.2900
-5.15%
 
CNTA Centessa Pharmaceuticals plc
12.30
-0.73%
 
APM Aptorum Group Limited
0.8609
-3.81%
 
VIRX Viracta Therapeutics, Inc.
0.0188
+10.59%
 
COYA Coya Therapeutics, Inc.
6.05
-2.58%
 
LENZ LENZ Therapeutics, Inc.
26.34
+1.82%
 
XOMA XOMA Royalty Corporation
24.19
-1.02%
 
XRTX XORTX Therapeutics Inc.
1.0200
0.00%